Menstrual Cycle TMS Plasticity Pilot
University of Pennsylvania · NCT07180654
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 20–40 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 100
- US sites recruiting
- 1
- Study start
- December 15, 2025
- Record last updated
- January 9, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
Aim 1: Assess how menstrual cycle phase affects motor cortex plasticity in females.
Aim 2: Compare motor cortex plasticity between males and females across the same time points, identifying potential sex differences in TMS response.
Aim 3: Examine associations between serum hormone levels and TMS-induced plasticity within and between sexes.
Being studied: transcranial magnetic stimulation
Conditions: Cortical Activation
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Able to give their consent
- If female, must have menstrual cycles of normal frequency, regularity, and duration.
Exclusion Criteria
- Non-English speaking
- Any medical condition that increases risk for TMS
- History of seizure
- History of epilepsy
- Increased risk of seizure for any reason
Recruiting US locations
University of Pennsylvania
Philadelphia, PA 19104
Site contact: Nicholas l Balderston, PhD · 215-746-3058 · nicholas.balderston@pennmedicine.upenn.edu
Study contacts (from the official record)
- Nicholas Balderston, PhD · 12157463058 · nicholas.balderston@pennmedicine.upenn.edu
Similar studies in Pennsylvania
All women’s health studies in Pennsylvania →- RecruitingHealthy volunteersEarly Phase 1
Endometriosis and Microvascular Dysfunction: Role of Inflammation
Penn State University
- Location
- University Park, PA
- Eligibility basics
- Ages 18–45 · Women only
- RecruitingPhase 2
A Study to Investigate Mibavademab in Adult Women With Functional Hypothalamic Amenorrhea
Regeneron Pharmaceuticals
- Location
- Erie, PA + 9 other US sites
- Eligibility basics
- Ages 18–40 · Women only
- RecruitingPhase 3
Human Menopausal Gonadotropin Research in Infertility Assessing Cumulative Live Birth With Frozen Embryo Transfer.
Granata Bio Corporation
- Location
- Bryn Mawr, PA + 14 other US sites
- Eligibility basics
- Ages 18–42 · Women only
- RecruitingPhase 2
HMBeacon: A Phase 2 Study to Evaluate ALN-6400 in Adult and Adolescent Female Patients With VWD and HMB
Alnylam Pharmaceuticals
- Location
- Pittsburgh, PA + 5 other US sites
- Eligibility basics
- Ages 16–45 · Women only